Close Menu
    What's Hot

    FQ-42 Vengeance Finds New Home at Creech Air Force Base

    September 21, 2026

    Typhoon Dujuan hits eastern Japan with heavy rain

    September 21, 2026

    China holds 3% one-year LPR and 3.5% mortgage benchmark

    September 21, 2026
    Tel Aviv GazetteTel Aviv Gazette
    • Automotive
    • Business
    • Entertainment
    • Health
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Tel Aviv GazetteTel Aviv Gazette
    Home » Arasan MIPI DSI-2 Rx Controller achieves ISO 26262 ASIL-B Certification
    PR Newswire

    Arasan MIPI DSI-2 Rx Controller achieves ISO 26262 ASIL-B Certification

    August 26, 2025
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    Arasan Chip Systems, a leading provider of semiconductor IP for automobile SoCs, today announced that its MIPI DSI-2 Rx IP has achieved ISO26262 ASIL-B automotive certification

    SAN JOSE, Calif., Aug. 26, 2025 /PRNewswire/ — Arasan Chip Systems, a leading provider of semiconductor IP for mobile and automobile SoCs, today announced the immediate availability of its ISO26262 ASIL-B Certified MIPI DSI-2 Rx Controller for mobile and automobile SoCs. The certification applies to the latest generation of Arasan’s MIPI DSI IP.

    Arasan MIPI DSI-2 Rx IP ISO26262 ASIL-B Certification

    The ISO26262 ASIL-B certification signifies that Arasan’s DSI-2 Rx Controller meets the stringent safety requirements for automotive System-On-Chips (SoCs). Additionally, the certification extends its usability to defense, aircraft, and other industries that require failsafe operation.

    Arasan’s Total Display IP Solution comprises of Arasan’s VESA DSC Encoder IP, VESA Decoder IP, Arasan DSI Tx & Rx IP for Low resolution displays like those found on IoT devices and wearables like fitness bands, sensors and smartwatches, Arasan DSI-2 Tx & Rx IP for Hi-Resolution displays with both versions of its MIPI Display IP seamlessly integrated with our MIPI D-PHY IP or C/D-PHY Combo IP. Arasan offers an ultra low power consumption D-PHY IP operating at 1.5gig specifically targeting the wearables market for use with its DSI IP.

    Arasan also offers its ASIL-C certified CAN 2.0 IP, CAN FD IP and CAN XP IP in addition to its LIN IP and Ethernet Controller IP core as part of its automotive IP offering.

    A demonstration of of Arasan’s MIPI DSI-2 IP seamlessly integrated with our C/D-PHY Combo ASIC on a MIPI Compliance Tester can be found here:

    https://youtu.be/lmC50LjFwXQ?si=pDxISVdMZL1blya9

    More information on Arasan DSI-2 Rx Controller IP can be found here:

    https://www.arasan.com/products/mipi/dsi/dsi-2-rx/

    Availability

    The Arasan MIPI DSI-2 Rx Controller IP is available immediately for ASIC and FPGA applications. Please contact bonnie.noufer@arasan.com for product enquiries.

    Media Contact:
    Bonnie Noufer
    bonnie.noufer@arasan.com

    About Arasan:
    Arasan Chip Systems is a leading provider of IP for mobile storage and mobile connectivity interfaces, with over a billion chips shipped with our IP. Our high-quality, silicon-proven Total IP Solutions encompass digital IP, Analog Mixed Signal PHY IP, Verification IP, HDK, and Software. With a strong focus on mobile SoCs, we have been at the forefront of the Mobile evolution since the mid-90s, supporting various mobile devices, including smartphones, automobiles, drones, and IoT devices, with our standards-based IP.

    Photo – https://mma.prnewswire.com/media/2756429/DSI2RX_ASIL_Certification_001.jpg

    Logo – https://mma.prnewswire.com/media/2724571/5473449/Arasan_Chip_Systems_Inc_Logo.jpg

    Cision View original content:https://www.prnewswire.com/il/news-releases/arasan-mipi-dsi-2-rx-controller-achieves-iso-26262-asil-b-certification-302537025.html

    Related Posts

    Jiahui Health Highlights China’s Growing Role in Global Medical Tourism at WTO Public Forum 2026

    September 18, 2026

    Cellebrite Expands Global Digital Community, ‘The 101’, for Digital Forensics and Investigative Professionals

    September 17, 2026

    CGX&OCR Brings Chinese Innovation to the Global Obstacle Racing Stage

    September 17, 2026

    Lutris Pharma to Present Updated Data from Its Phase 2 Trial of LUT014 Gel for the Treatment of Patients With EGFRI-Induced Acneiform Rash at the EADV Congress

    September 16, 2026

    Nitinotes Announces First EASE™ Clinical Trial Procedures at Fondazione Policlinico Universitario Agostino Gemelli IRCCS in Italy

    September 15, 2026

    Cellebrite CTO Chris Wade to Lead Cellebrite Labs, Sharpening Focus on Mobile Research

    September 14, 2026
    Editor's Pick

    Typhoon Dujuan hits eastern Japan with heavy rain

    September 21, 2026

    China holds 3% one-year LPR and 3.5% mortgage benchmark

    September 21, 2026

    Gene could raise lung cancer risk 60 times in study

    September 19, 2026

    DR Congo Ebola outbreak shows progress amid uneven trends

    September 17, 2026
    © 2026 Tel Aviv Gazette | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.